Product Information

EVOTAZ 300 MG-150 MG TABLET is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $51.9820 per EA under NDC 00003364111. Its NADAC has been published 541 times since Jun 17, 2015.

EVOTAZ 300 MG-150 MG TABLET

atazanavir and cobicistat

$51.9820per EA

Strength

300; 150 mg/1; mg/1

Manufacturer

E.R. Squibb & Sons, L.L.C.

NDC

00003364111

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

ATAZANAVIR SULFATE; COBICISTAT

Approval Type

New Drug (NDA)

FDA Application

NDA206353

On Market Since

1/29/2015

Pharmacological Classes

Breast Cancer Resistance Protein Inhibitors

Cytochrome P450 2C8 Inhibitors

Cytochrome P450 2D6 Inhibitors

Cytochrome P450 3A Inhibitor

Cytochrome P450 3A Inhibitors

Cytochrome P450 3A4 Inhibitors

HIV Protease Inhibitors

Multidrug and Toxin Extrusion Transporter 1 Inhibitors

Organic Anion Transporting Polypeptide 1B1 Inhibitors

Organic Anion Transporting Polypeptide 1B3 Inhibitors

P-Glycoprotein Inhibitors

Protease Inhibitor

UDP Glucuronosyltransferases Inhibitors

UGT1A1 Inhibitors

Price Statistics

The NADAC for EVOTAZ 300 MG-150 MG TABLET has been published 541 times since Jun 17, 2015, and over the history we have for it it has risen 15.4%. The table below summarizes its recorded NADAC range and movement.

Current price	$51.9820 per EA
All-time high	$52.1041 (Feb 15, 2017)
All-time low	$44.9016 (Jul 22, 2015)
52-week high	$52.0785
52-week low	$51.9394
Median price	$51.9275
Average price	$51.1510
Largest weekly change	+7.9% (Jan 13, 2016)
Weeks tracked	541
Tracking since	Jun 17, 2015

Price History

0.0%

-0.0%

+0.0%

-0.1%

-0.2%

+0.1%

All

+15.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the atazanavir and cobicistat market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of EVOTAZ 300 MG-150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EVOTAZ 300 MG-150 MG TABLET, manufactured by E.R. Squibb & Sons, L.L.C., is $51.9820 per EA (NDC 00003364111), effective Jun 24, 2026.

How has the price of EVOTAZ 300 MG-150 MG TABLET changed over time?

Over the history we have for it, the NADAC for EVOTAZ 300 MG-150 MG TABLET has risen 15.4%. It has been tracked across 541 weekly CMS publications since Jun 17, 2015.

What are the highest and lowest recorded NADAC prices for EVOTAZ 300 MG-150 MG TABLET?

Since Jun 17, 2015, the NADAC for EVOTAZ 300 MG-150 MG TABLET has ranged from a low of $44.9016 (Jul 22, 2015) to a high of $52.1041 (Feb 15, 2017), with a median of $51.9275 per EA.

Are there cheaper alternatives to EVOTAZ 300 MG-150 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of EVOTAZ 300 MG-150 MG TABLET, so no direct lower-cost alternative is listed.